Trials / Completed
CompletedNCT05279833
Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation
SLR/NMA of Multaq® vs Sotalol to Assess for Safety in Patients With Atrial Fibrillation (AFib)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87,810 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A systematic literature review (SLR) will be conducted to understand the landscape of evidence on the relative safety and effectiveness/efficacy of dronedarone compared to sotalol in patients with AFib within interventional clinical trials and observational studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dronedarone | Pharmaceutical form is tablet and route of administration is oral |
| DRUG | sotalol | Pharmaceutical form is tablet and route of administration is oral |
Timeline
- Start date
- 2021-09-24
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
- First posted
- 2022-03-15
- Last updated
- 2024-01-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05279833. Inclusion in this directory is not an endorsement.